23,424 Shares in National Health Investors, Inc. $NHI Acquired by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 23,424 shares of the real estate investment trust’s stock, valued at approximately $1,786,000.

Several other hedge funds also recently bought and sold shares of NHI. International Assets Investment Management LLC purchased a new position in National Health Investors in the 4th quarter worth about $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors during the 4th quarter worth $33,000. Advisory Services Network LLC bought a new stake in shares of National Health Investors in the 3rd quarter valued at about $65,000. Finally, Triumph Capital Management acquired a new stake in National Health Investors in the third quarter valued at approximately $66,000. Institutional investors own 62.51% of the company’s stock.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction on Friday, June 5th. The stock was acquired at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 2.70% of the company’s stock.

National Health Investors Stock Performance

NYSE:NHI opened at $73.59 on Friday. The firm has a market capitalization of $3.61 billion, a price-to-earnings ratio of 21.27, a PEG ratio of 3.39 and a beta of 0.51. National Health Investors, Inc. has a 1-year low of $67.94 and a 1-year high of $91.38. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The company’s 50-day moving average is $75.48 and its two-hundred day moving average is $79.10.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.National Health Investors’s revenue was up 1.6% compared to the same quarter last year. During the same period last year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts forecast that National Health Investors, Inc. will post 4.77 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.0%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is 106.36%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. BMO Capital Markets dropped their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Truist Financial reduced their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Wells Fargo & Company cut their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.